144 related articles for article (PubMed ID: 27888699)
1. Tumor detection using magnetosome nanoparticles functionalized with a newly screened EGFR/HER2 targeting peptide.
Xiang Z; Yang X; Xu J; Lai W; Wang Z; Hu Z; Tian J; Geng L; Fang Q
Biomaterials; 2017 Jan; 115():53-64. PubMed ID: 27888699
[TBL] [Abstract][Full Text] [Related]
2. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
[TBL] [Abstract][Full Text] [Related]
3. Genetically tailored magnetosomes used as MRI probe for molecular imaging of brain tumor.
Boucher M; Geffroy F; Prévéral S; Bellanger L; Selingue E; Adryanczyk-Perrier G; Péan M; Lefèvre CT; Pignol D; Ginet N; Mériaux S
Biomaterials; 2017 Mar; 121():167-178. PubMed ID: 28088078
[TBL] [Abstract][Full Text] [Related]
4. Preparation and
Okarvi SM; Aljammaz I
Anticancer Res; 2018 May; 38(5):2823-2830. PubMed ID: 29715105
[TBL] [Abstract][Full Text] [Related]
5. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe
Li L; Wu Y; Wang Z; Jia B; Hu Z; Dong C; Wang F
J Nucl Med; 2017 May; 58(5):821-826. PubMed ID: 28104744
[TBL] [Abstract][Full Text] [Related]
6. Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas.
Okarvi SM; AlJammaz I
Molecules; 2019 Aug; 24(17):. PubMed ID: 31470531
[TBL] [Abstract][Full Text] [Related]
7. Bispecific Antibody Conjugated Manganese-Based Magnetic Engineered Iron Oxide for Imaging of HER2/neu- and EGFR-Expressing Tumors.
Wu SC; Chen YJ; Wang HC; Chou MY; Chang TY; Yuan SS; Chen CY; Hou MF; Hsu JT; Wang YM
Theranostics; 2016; 6(1):118-30. PubMed ID: 26722378
[TBL] [Abstract][Full Text] [Related]
8. Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer.
Chen H; Wang L; Yu Q; Qian W; Tiwari D; Yi H; Wang AY; Huang J; Yang L; Mao H
Int J Nanomedicine; 2013; 8():3781-94. PubMed ID: 24124366
[TBL] [Abstract][Full Text] [Related]
9.
Kwon LY; Scollard DA; Reilly RM
Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
[TBL] [Abstract][Full Text] [Related]
10. Smart Bacterial Magnetic Nanoparticles for Tumor-Targeting Magnetic Resonance Imaging of HER2-Positive Breast Cancers.
Zhang Y; Ni Q; Xu C; Wan B; Geng Y; Zheng G; Yang Z; Tao J; Zhao Y; Wen J; Zhang J; Wang S; Tang Y; Li Y; Zhang Q; Liu L; Teng Z; Lu G
ACS Appl Mater Interfaces; 2019 Jan; 11(4):3654-3665. PubMed ID: 30495920
[TBL] [Abstract][Full Text] [Related]
11. HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery.
Geng L; Wang Z; Jia X; Han Q; Xiang Z; Li D; Yang X; Zhang D; Bu X; Wang W; Hu Z; Fang Q
Theranostics; 2016; 6(8):1261-73. PubMed ID: 27279916
[TBL] [Abstract][Full Text] [Related]
12. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
[TBL] [Abstract][Full Text] [Related]
13. Structure-based Design of Peptides with High Affinity and Specificity to HER2 Positive Tumors.
Geng L; Wang Z; Yang X; Li D; Lian W; Xiang Z; Wang W; Bu X; Lai W; Hu Z; Fang Q
Theranostics; 2015; 5(10):1154-65. PubMed ID: 26284145
[TBL] [Abstract][Full Text] [Related]
14. Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.
Li X; Xia S; Zhou W; Ji R; Zhan W
Int J Nanomedicine; 2019; 14():2397-2413. PubMed ID: 31040664
[TBL] [Abstract][Full Text] [Related]
15. Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo.
Guan SS; Wu CT; Chiu CY; Luo TY; Wu JY; Liao TZ; Liu SH
J Transl Med; 2018 Jun; 16(1):168. PubMed ID: 29921305
[TBL] [Abstract][Full Text] [Related]
16. Erlotinib-Conjugated Iron Oxide Nanoparticles as a Smart Cancer-Targeted Theranostic Probe for MRI.
Ali AA; Hsu FT; Hsieh CL; Shiau CY; Chiang CH; Wei ZH; Chen CY; Huang HS
Sci Rep; 2016 Nov; 6():36650. PubMed ID: 27833124
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional superparamagnetic nanoparticles conjugated with fluorescein-labeled designed ankyrin repeat protein as an efficient HER2-targeted probe in breast cancer.
Li DL; Tan JE; Tian Y; Huang S; Sun PH; Wang M; Han YJ; Li HS; Wu HB; Zhang XM; Xu YK; Wang QS
Biomaterials; 2017 Dec; 147():86-98. PubMed ID: 28938164
[TBL] [Abstract][Full Text] [Related]
18. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI.
Chen TJ; Cheng TH; Chen CY; Hsu SC; Cheng TL; Liu GC; Wang YM
J Biol Inorg Chem; 2009 Feb; 14(2):253-60. PubMed ID: 18975017
[TBL] [Abstract][Full Text] [Related]
19. Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.
Yamaguchi H; Tsuchimochi M; Hayama K; Kawase T; Tsubokawa N
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399687
[TBL] [Abstract][Full Text] [Related]
20. MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using ¹¹¹In-labeled bispecific radioimmunoconjugates.
Razumienko E; Dryden L; Scollard D; Reilly RM
Breast Cancer Res Treat; 2013 Apr; 138(3):709-18. PubMed ID: 23525982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
